NYU Researchers Launch AI Tool for Better Drug Discovery

New 'Tautomer-Predictor' identifies stable molecular forms to improve pharmaceutical modeling accuracy.

By Kronos News Desk··1 min read
A 3D visualization of a complex chemical molecule with glowing bonds, representing AI-driven molecular modeling for drug discovery.

A 3D visualization of a complex chemical molecule with glowing bonds, representing AI-driven molecular modeling for drug discovery.

Photo: Kronos News

Researchers at New York University released an open-source AI tool called 'Tautomer-Predictor' on September 24, 2026. [1] The model accurately identifies the most stable forms of drug-like molecules, known as tautomers. [1][2] This tool helps scientists correctly position hydrogen atoms during the molecular design process. [1][3]

Correctly modeling these structures is a major challenge in drug discovery. [2] Small shifts in hydrogen positions can change how a molecule interacts with target proteins. [2][3] By addressing this bottleneck, the researchers aim to reduce failures in protein-ligand interaction modeling and accelerate medical breakthroughs. [1][2]

Editorial notes

Transparency note

AI assisted drafting. Human edited and reviewed.

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Low

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Get the weekly briefing

A concise briefing with selected stories and analysis.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Kronos News Desk covers news and editorial analysis for Kronos News.